BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 24890943)

  • 21. Expression of FSCN1 and FOXM1 are associated with poor prognosis of adrenocortical carcinoma patients.
    Liang J; Liu Z; Wei X; Zhou L; Tang Y; Zhou C; Wu K; Zhang F; Zhang F; Lu Y; Zhu Y
    BMC Cancer; 2019 Nov; 19(1):1165. PubMed ID: 31783819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic and prognostic assessments of adrenocortical carcinomas by pathological features, immunohistochemical markers and reticular histochemistry staining.
    Gan W; Han X; Gong Y; Yang Y; Wang C; Zhang Z
    Diagn Pathol; 2024 May; 19(1):71. PubMed ID: 38802933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-483-5p and miR-139-5p promote aggressiveness by targeting N-myc downstream-regulated gene family members in adrenocortical cancer.
    Agosta C; Laugier J; Guyon L; Denis J; Bertherat J; Libé R; Boisson B; Sturm N; Feige JJ; Chabre O; Cherradi N
    Int J Cancer; 2018 Aug; 143(4):944-957. PubMed ID: 29516499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survivin in adrenocortical tumors - pathophysiological implications and therapeutic potential.
    Sbiera S; Kroiss M; Thamm T; Beyer M; Majidi F; Kuehner D; Wobser M; Becker JC; Adam P; Ronchi C; Allolio B; Fassnacht M
    Horm Metab Res; 2013 Feb; 45(2):137-46. PubMed ID: 23143666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathological stage-associated non-coding RNA long intergenic non-protein coding RNA 1234 (LINC01234) participation in cell cycle regulation in adrenocortical carcinoma through bromodomain-containing protein 4 (BRD4) expression mediation via sponging microRNA (miR)-140-3p.
    Zhu DD; Yu XB; Jiang W; Zhu Y
    Bioengineered; 2022 May; 13(5):13607-13621. PubMed ID: 35765893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential expression of microRNA-675, microRNA-139-3p and microRNA-335 in benign and malignant adrenocortical tumours.
    Schmitz KJ; Helwig J; Bertram S; Sheu SY; Suttorp AC; Seggewiss J; Willscher E; Walz MK; Worm K; Schmid KW
    J Clin Pathol; 2011 Jun; 64(6):529-35. PubMed ID: 21471143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myxoid adrenocortical neoplasms: a study of the clinicopathologic features and EGFR gene status of ten Chinese cases.
    Zhang J; Sun J; Liang Z; Gao J; Zeng X; Liu T
    Am J Clin Pathol; 2011 Nov; 136(5):783-92. PubMed ID: 22031318
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinguishing adrenal cortical carcinomas and adenomas: a study of clinicopathological features and biomarkers.
    Wang C; Sun Y; Wu H; Zhao D; Chen J
    Histopathology; 2014 Mar; 64(4):567-76. PubMed ID: 24102952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA and kinetic heterogeneity during the clonal evolution of adrenocortical proliferative lesions.
    Blanes A; Diaz-Cano SJ
    Hum Pathol; 2006 Oct; 37(10):1295-303. PubMed ID: 16949934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunohistochemical evaluation of metallothionein, Mcm-2 and Ki-67 antigen expression in tumors of the adrenal cortex.
    Szajerka A; Dziegiel P; Szajerka T; Zabel M; Winowski J; Grzebieniak Z
    Anticancer Res; 2008; 28(5B):2959-65. PubMed ID: 19031940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low DICER1 expression is associated with poor clinical outcome in adrenocortical carcinoma.
    de Sousa GR; Ribeiro TC; Faria AM; Mariani BM; Lerario AM; Zerbini MC; Soares IC; Wakamatsu A; Alves VA; Mendonca BB; Fragoso MC; Latronico AC; Almeida MQ
    Oncotarget; 2015 Sep; 6(26):22724-33. PubMed ID: 26087193
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microarray gene expression and immunohistochemistry analyses of adrenocortical tumors identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomas.
    Soon PS; Gill AJ; Benn DE; Clarkson A; Robinson BG; McDonald KL; Sidhu SB
    Endocr Relat Cancer; 2009 Jun; 16(2):573-83. PubMed ID: 19218281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene expression profiling in adrenocortical neoplasia.
    Assie G; Giordano TJ; Bertherat J
    Mol Cell Endocrinol; 2012 Mar; 351(1):111-7. PubMed ID: 22056416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histopathological study of adrenocortical carcinoma with special reference to the Weiss system and TNM staging and the role of immunohistochemistry to differentiate it from renal cell carcinoma.
    Mondal SK; Dasgupta S; Jain P; Mandal PK; Sinha SK
    J Cancer Res Ther; 2013; 9(3):436-41. PubMed ID: 24125979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrated genome-wide analysis of genomic changes and gene regulation in human adrenocortical tissue samples.
    Gara SK; Wang Y; Patel D; Liu-Chittenden Y; Jain M; Boufraqech M; Zhang L; Meltzer PS; Kebebew E
    Nucleic Acids Res; 2015 Oct; 43(19):9327-39. PubMed ID: 26446994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myxoid and Sarcomatoid Variants of Adrenocortical Carcinoma: Analysis of Rare Variants in Single Tertiary Care Center.
    Sung TY; Choi YM; Kim WG; Lee YM; Kim TY; Shong YK; Kim WB; Song DE
    J Korean Med Sci; 2017 May; 32(5):764-771. PubMed ID: 28378549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. microRNA portraits in human vulvar carcinoma.
    de Melo Maia B; Lavorato-Rocha AM; Rodrigues LS; Coutinho-Camillo CM; Baiocchi G; Stiepcich MM; Puga R; de A Lima L; Soares FA; Rocha RM
    Cancer Prev Res (Phila); 2013 Nov; 6(11):1231-41. PubMed ID: 24048714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Squamous cell carcinoma-related oncogene is highly expressed in developing, normal, and adenomatous adrenal tissue but not in aggressive adrenocortical carcinomas.
    Sarkaria IS; Stojadinovic A; Talbot SG; Hoos A; Dudas ME; Brennan MF; Ghossein RA; Singh B
    Surgery; 2004 Dec; 136(6):1122-8. PubMed ID: 15657565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adrenocortical adenoma and carcinoma: histopathological and molecular comparative analysis.
    Stojadinovic A; Brennan MF; Hoos A; Omeroglu A; Leung DH; Dudas ME; Nissan A; Cordon-Cardo C; Ghossein RA
    Mod Pathol; 2003 Aug; 16(8):742-51. PubMed ID: 12920217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific MicroRNAs Differentiate Adrenocortical Adenomas from Carcinomas and Correlate With Weiss Histopathologic System.
    Feinmesser M; Benbassat C; Meiri E; Benjamin H; Lebanony D; Lebenthal Y; de Vries L; Drozd T; Spector Y
    Appl Immunohistochem Mol Morphol; 2015 Aug; 23(7):522-31. PubMed ID: 25265426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.